ArticlePloS one2025

Screening potential anti-osteoarthritis compounds using molecular docking based on MAPK and NFκB pathways and validating their anti-osteoarthritis effect.

Tian-Wang Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.